Hematite nanoparticles (α−Fe2O3 NPs) were synthesized through a thermal conversion of synthetic and biosynthesized nanomaghemite (γ−Fe2O3 NPs) precursors. X-ray diffraction data confirmed phase-pure hematite with crystallite sizes of 54 and 56 nm for the H1 and H2 samples, respectively. Transmission electron microscopy (TEM) revealed a bimodal-like distribution feature (peaks at 18.5 and 35.5 nm) for the H1 sample, while the histogram plot of the H2 sample displayed a homogeneous particle size distribution with a mean size of 28 nm. X-ray photoelectron spectroscopy confirmed Fe3+ ions as the dominant oxidation state in both samples. In addition, while 57Mössbauer spectroscopy indicated relaxation effects and line broadening for the H1 sample at both 300 K and 16 K, consistent with incomplete γ→α transformation, the H2 sample exhibited spectra at the same temperatures resembling a bulk-like hematite. Magnetometry supported these findings since the H1 sample showed enhanced coercivity (2.2 kOe) and remanence (0.23 emu/g), features attributed to a residual ferrimagnetic contribution of γ−Fe2O3 NPs, and the H2 sample exhibited weaker ferromagnetism, as typically found in nanoscale hematite. These results highlight the synergistic use of X-ray photoelectron and Mössbauer spectroscopies, and magnetic measurements to reveal subtle multiphase coexistence, demonstrating that precursor chemistry and biosynthetic functionalization decisively govern the structural and magnetic evolution of γ→α−Fe2O3 NPs.
Ramos‐Guivar et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: